Dashboard
Manage Tickers

ACETAdicet Bio, Inc.

Nasdaq adicetbio.com


$ 1.54 $ -0.07 (-4.35 %)    

Friday, 13-Sep-2024 12:19:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 474.62 $ 1.19 (0.25 %)
DIA $ 415.14 $ 2.51 (0.61 %)
SPY $ 561.73 $ 1.46 (0.26 %)
TLT $ 100.33 $ -0.15 (-0.15 %)
GLD $ 238.79 $ 1.21 (0.51 %)
$ 1.53
$ 1.61
$ 1.53 x 200
$ 1.54 x 400
$ 1.54 - $ 1.61
$ 1.05 - $ 3.77
859,862
na
126.07M
$ 1.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-19-2024 12-31-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-09-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-15-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-10-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-15-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-17-2021 03-31-2021 10-Q
15 03-12-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 07-31-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 03-12-2020 12-31-2019 10-K
20 11-05-2019 09-30-2019 10-Q
21 08-14-2019 06-30-2019 10-Q
22 05-15-2019 03-31-2019 10-Q
23 03-18-2019 12-31-2018 10-K
24 11-13-2018 09-30-2018 10-Q
25 08-09-2018 06-30-2018 10-Q
26 05-10-2018 03-31-2018 10-Q
27 03-29-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

this-novartis-analyst-is-no-longer-bullish-here-are-top-downgrades-for-wednesday
This Novartis Analyst Is No Longer Bullish...
09/11/2024 16:13:54

jones-trading-maintains-buy-on-adicet-bio-lowers-price-target-to-4
Jones Trading Maintains Buy on Adicet Bio,...
09/11/2024 15:48:21

Jones Trading analyst Soumit Roy maintains Adicet Bio (NASDAQ:ACET) with a Buy and lowers the price target from $6 to $4.

canaccord-genuity-maintains-buy-on-adicet-bio-lowers-price-target-to-8
Canaccord Genuity Maintains Buy on Adicet ...
09/11/2024 15:25:48

Canaccord Genuity analyst John Newman maintains Adicet Bio (NASDAQ:ACET) with a Buy and lowers the price target from $19 to $8.

hc-wainwright--co-downgrades-adicet-bio-to-neutral
HC Wainwright & Co. Downgrades Adicet Bio ...
09/11/2024 10:18:49

HC Wainwright & Co. analyst Edward White downgrades Adicet Bio (NASDAQ:ACET) from Buy to Neutral.

adicet-bio-shifts-focus-to-autoimmune-diseases-closes-lymphoma-trial-for-adi-001
Adicet Bio Shifts Focus to Autoimmune Dise...
09/10/2024 11:10:42

On September 10, 2024, Adicet Bio, Inc. (the Company or Adicet) announced a strategic prioritization to focus ADI-001 developme...

hc-wainwright--co-reiterates-buy-on-adicet-bio-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Adic...
08/14/2024 17:34:17

HC Wainwright & Co. analyst Edward White reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $10 price target.

canaccord-genuity-maintains-buy-on-adicet-bio-maintains-19-price-target
Canaccord Genuity Maintains Buy on Adicet ...
08/14/2024 13:40:06

Canaccord Genuity analyst John Newman maintains Adicet Bio (NASDAQ:ACET) with a Buy and maintains $19 price target.

adicet-bio-q2-2024-gaap-eps-033-beats-036-estimate-cash-and-cash-equivalents-were-2241m-will-be-sufficient-to-fund-its-operating-expenses-into-the-second-half-of-2026
Adicet Bio Q2 2024 GAAP EPS $(0.33) Beats ...
08/13/2024 11:13:07

hc-wainwright--co-reiterates-buy-on-adicet-bio-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Adic...
07/08/2024 14:00:35

HC Wainwright & Co. analyst Edward White reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $10 price target.

the-fda-has-granted-fast-track-designation-to-adicet-bios-adi-270-for-metastaticadvanced-clear-cell-renal-cell-carcinoma-patients-who-have-been-treated-with-an-immune-checkpoint-inhibitor-and-a-vascular-endothelial-growth-factor-inhibitor
The FDA Has Granted Fast Track Designation...
07/08/2024 11:13:46

hc-wainwright--co-reiterates-buy-on-adicet-bio-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Adic...
06/24/2024 14:55:32

HC Wainwright & Co. analyst Edward White reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $10 price target.

adicet-bio-announces-fda-clearance-of-its-ind-application-for-adi-270-in-renal-cell-carcinoma
Adicet Bio Announces FDA Clearance Of Its ...
06/24/2024 11:11:12

hc-wainwright--co-reiterates-buy-on-adicet-bio-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Adic...
06/05/2024 15:23:05

HC Wainwright & Co. analyst Edward White reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $10 price target.

adicet-bio-says-fda-has-granted-fast-track-designation-to-adi-001-for-potential-treatment-of-relapsedrefractory-class-iii-or-class-iv-lupus-nephritis
Adicet Bio Says FDA Has Granted Fast Track...
06/05/2024 11:04:19

Fast Track Designation is a process designed to facilitate the development and expedite the review of drugs intended to treat s...

hc-wainwright--co-reiterates-buy-on-adicet-bio-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Adic...
05/15/2024 16:46:50

HC Wainwright & Co. analyst Edward White reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $10 price target.

adicet-bio-q1-2024-adj-eps-035-beats-039-estimate
Adicet Bio Q1 2024 Adj EPS $(0.35) Beats $...
05/14/2024 20:19:37

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.39) by...

adicet-bio-announces-poster-presentation-of-adi-270-preclinical-data-at-the-2024-eha-hybrid-congress
Adicet Bio Announces Poster Presentation O...
05/14/2024 14:07:57

Adicet Bio, Inc. (NASDAQ:ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell...

wedbush-reiterates-outperform-on-adicet-bio-maintains-5-price-target
Wedbush Reiterates Outperform on Adicet Bi...
04/23/2024 16:29:30

Wedbush analyst Robert Driscoll reiterates Adicet Bio (NASDAQ:ACET) with a Outperform and maintains $5 price target.

adicet-today-presented-abstract-featuring-preclinical-data-highlighting-adi-270-at-asgct27th-annual-meeting
Adicet Today Presented Abstract Featuring ...
04/22/2024 20:33:51

hc-wainwright--co-maintains-buy-on-adicet-bio-maintains-10-price-target
HC Wainwright & Co. Maintains Buy on Adice...
04/02/2024 12:42:01

HC Wainwright & Co. analyst Edward White maintains Adicet Bio (NASDAQ:ACET) with a Buy and maintains $10 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION